Department of Medicine 4 – Nephrology and Hypertension

The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry (2015) Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, et al. Journal article Lungen- und Nierenversagen - Pathogenese, Wechselwirkungen und Therapie (2015) John S, Willam C Journal article, Editorial Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease (2015) Wagner M, Ashby DR, Kurtz C, Alam A, Busbridge M, Raff U, Zimmermann J, et al. Journal article Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs? (2015) Mann J, Rossing P, Wiecek A, Rosivall L, Mark P, Mayer G Journal article Diagnostik und Therapie der Nephrolithiasis (2015) Pfau A, Eckardt KU, Knauf F Journal article Glutathione peroxidase 8 is transcriptionally regulated by HIF? and modulates growth factor signaling in HeLa cells (2015) Bosello-Travain V, Forman HJ, Roveri A, Toppo S, Ursini F, Venerando R, Warnecke C, et al. Journal article Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study (2015) Gillespie IA, Macdougall IC, Richards S, Jones V, Marcelli D, Froissart M, Eckardt KU Journal article Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates (2015) Schneider MP, Hübner S, Titze S, Schmid M, Nadal J, Schlieper G, Busch M, et al. Journal article Managing Treatment-Resistant Patients (2015) Schmieder R Journal article, Review article Aldosterone antagonists and renal denervation: friends or foes? (2015) Mahfoud F, Ruilope LM, Bohm M, Schmieder R Journal article, Editorial